Mind Cure Closes $3.6 Million Oversubscribed Financing

Mind Cure Health (CSE: MCUR) reported midday today that it has closed its non-brokered private placement on an oversubscribed basis. The company managed to raise $3.6 million via the sale of 8.0 million units of the company.

The financing conducted, which was to originally be for $3.0 million, saw units sold at a price of $0.45 each. Each unit contained one common share and one common share purchase warrant, with warrants exerciseable at a price of $0.60 per share for a period of two years after the date of issue.

Commenting on the financing, CEO and Chairman Philip Tapley stated, “The world-class team we are assembling here at Mind Cure is already hard at work, and this financing enables us to accelerate our operations. We firmly believe that investment and innovation can work hand in hand, and we look forward to delivering value to our shareholders as we establish ourselves as a leader in the mental health revolution.”

Following the close of the financing, the company indicated that it now has cash on hand in excess of $5.0 million, enabling Mind Cure to “focus on rapid tactical execution” of its strategic plan. Proceeds from the financing will be used for the evaluation of new product candidates, psychedelic product research, and supporting the existing product line among other uses.

Mind Cure Health last traded at $0.50 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

$30,000 GOLD: How Trump’s Policies Could Trigger The Next Price Explosion | Simon Marcotte

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Mind Cure To Acquire LNG Energy Group In RTO Deal

Mind Cure Health (CSE: MCUR) is set to enter the energy sector. The firm this...

Friday, November 18, 2022, 09:32:12 AM

Mind Cure Receives Health Canada Approval For Sale Of Moonbeam Mushroom Products

Mind Cure Health (CSE: MCUR) has received the required authorizations from Health Canada for its...

Wednesday, September 23, 2020, 08:33:06 AM

Mindcure Ends Fiscal Q1 2022 With $15.6 Million Cash & Cash Equivalents, $2.8 Million Net Loss

Mind Cure Health (CSE: MCUR) announced on Tuesday the financial results for the three months ended...

Wednesday, October 27, 2021, 10:41:00 AM

Mindcure Completes Beta Testing, Launches PsyCollage

Mind Cure Health (CSE: MCUR) has completed the beta testing phase for its proprietary bioinformatics...

Tuesday, February 16, 2021, 07:22:53 AM

Mind Cure To See Nootropics Sold Across North America Via Body Energy Club

Mind Cure Health (CSE: MCUR) this morning released further plans related to the launch of...

Thursday, December 31, 2020, 09:17:25 AM